Stock Price
237.00
Daily Change
-3.30 -1.37%
Monthly
-8.39%
Yearly
49.48%
Q2 Forecast
229.11

UCB reported EUR6.05B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Alcon AG USD 6.62B 171M Mar/2026
Almirall EUR 713.98M 69K Dec/2025
Amarin USD 626.02M 23.87M Mar/2026
argenx SE USD 6.9B 1.07B Dec/2025
AstraZeneca USD 29.61B 890M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lakefront Biotherapeutics EUR 3.06B 18.72M Mar/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Novartis USD 26.61B 3.85B Mar/2026
Orion EUR 1.41B 66.8M Mar/2026
Recordati EUR 1.68B 35.91M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
UCB EUR 6.05B 733M Dec/2025
Unibail Rodamco EUR 3.97B 1.09B Dec/2025